Upregulation of CD9 in ovarian cancer is related to the induction of TNF-α gene expression and constitutive NF-κB activation

Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia

(2011) Hiroto Yamazaki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer

(2011) Q Sheng et al.   BRITISH JOURNAL OF CANCER

Towards detecting the HER-2 receptor and metabolic changes induced by HER-2-targeted therapies using medical imaging

(2010) T A D Smith   BRITISH JOURNAL OF RADIOLOGY

Cell Surface Tetraspanin CD9 Mediates Chemoresistance in Small Cell Lung Cancer

(2010) S. Kohmo et al.   CANCER RESEARCH

Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor  , in Epithelial Ovarian Cancer: a Phase I Study

(2010) J. A. Konner et al.   CLINICAL CANCER RESEARCH

The pathology of and controversial aspects of ovarian borderline tumours

(2010) W Glenn McCluggage   CURRENT OPINION IN ONCOLOGY

High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma

(2010) Chul Jung Kim et al.   EUROPEAN JOURNAL OF CANCER

TNF: a tumor-suppressing factor or a tumor-promoting factor?

(2010) Fran Balkwill et al.   Future Oncology

Expression of classical NF-κB pathway effectors in human ovarian carcinoma

(2010) Silvia Darb-Esfahani et al.   HISTOPATHOLOGY

Autoantibodies to Tumor-Associated Antigens in Epithelial Ovarian Carcinoma

(2010) Benjamin Piura et al.   Journal of Oncology

CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells

(2009) Hiroko Nishida et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A novel therapeutic strategy with anti-CD9 antibody in gastric cancers

(2009) Taisei Nakamoto et al.   JOURNAL OF GASTROENTEROLOGY

DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes

(2009) K Tanaka et al.   ONCOGENE

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling

(2008) L. Cao et al.   CARCINOGENESIS